Title:
COMPOUNDS POSSESSING PARP1 INHIBITORY ACTIVITY, AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/082654
Kind Code:
A1
Abstract:
Compounds having poly ADP-ribose polymerase inhibitory activity, pharmaceutical compositions thereof, and uses thereof are disclosed. In particular, the present invention relates to compounds of formula (I), pharmaceutical compositions comprising these compounds, and uses of these compounds in the preparation of pharmaceuticals for the prevention and/or treatment of diseases, especially diseases improved by inhibiting PARP1.
More Like This:
Inventors:
GAO SHANYUN (CN)
HOU YINGJIE (CN)
LI JINGJING (CN)
ZHANG CHAOBO (CN)
XU YANXIAO (CN)
TU WANGYANG (CN)
YU BING (CN)
ZHANG YIXIANG (CN)
LI LEPING (CN)
HOU YINGJIE (CN)
LI JINGJING (CN)
ZHANG CHAOBO (CN)
XU YANXIAO (CN)
TU WANGYANG (CN)
YU BING (CN)
ZHANG YIXIANG (CN)
LI LEPING (CN)
Application Number:
PCT/CN2023/099434
Publication Date:
April 25, 2024
Filing Date:
June 09, 2023
Export Citation:
Assignee:
HAIHE BIOPHARMA CO LTD (CN)
International Classes:
C07D471/04; A61K31/4965; A61P35/00
Domestic Patent References:
| WO2023138541A1 | 2023-07-27 | |||
| WO2023146960A1 | 2023-08-03 | |||
| WO2022222921A1 | 2022-10-27 | |||
| WO2022222995A1 | 2022-10-27 | |||
| WO2022228387A1 | 2022-11-03 | |||
| WO2023036285A1 | 2023-03-16 | |||
| WO2023046034A1 | 2023-03-30 | |||
| WO2023046149A1 | 2023-03-30 | |||
| WO2023046158A1 | 2023-03-30 | |||
| WO2023051807A1 | 2023-04-06 | |||
| WO2023051812A1 | 2023-04-06 |
Foreign References:
| CN115232121A | 2022-10-25 | |||
| CN115232154A | 2022-10-25 |
Attorney, Agent or Firm:
KINGSOUND & PARTNERS (CN)
Download PDF: